Thomas Luke

3.8k total citations · 2 hit papers
26 papers, 2.2k citations indexed

About

Thomas Luke is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas Luke has authored 26 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas Luke's work include Influenza Virus Research Studies (10 papers), Mosquito-borne diseases and control (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Thomas Luke is often cited by papers focused on Influenza Virus Research Studies (10 papers), Mosquito-borne diseases and control (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Thomas Luke collaborates with scholars based in United States, Australia and Egypt. Thomas Luke's co-authors include Stephen L. Hoffman, Jeffrey L. Jackson, Thomas L. Richie, Martha Sedegah, John B. Sacci, Patricia De La Vega, Kanakatte Raviprakash, Hanan H. Balkhy, Ali H. Hajeer and Robert Fowler and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Thomas Luke

26 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoites

2002 526 citations Stephen L. Hoffman, Thomas Luke et al. The Journal of Infectious Diseases profile →
Middle East Respiratory Syndrome

2017 373 citations Yaseen M. Arabi, Hanan H. Balkhy et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Luke United States	15	1.1k	875	405	367	357	26	2.2k
Bobbie R. Erickson United States	27	3.4k 3.0×	840 1.0×	400 1.0×	138 0.4×	296 0.8×	36	3.8k
Laurence Baril France	28	1.0k 0.9×	740 0.8×	687 1.7×	209 0.6×	170 0.5×	74	2.5k
Martin J. Vincent United States	20	2.9k 2.6×	690 0.8×	385 1.0×	152 0.4×	398 1.1×	22	3.5k
Mario Corbellino Italy	23	1.2k 1.1×	746 0.9×	735 1.8×	196 0.5×	205 0.6×	48	2.5k
Concetta Castilletti Italy	35	2.5k 2.2×	1.2k 1.4×	831 2.1×	701 1.9×	476 1.3×	160	3.8k
Ramesh Jadi United States	21	3.5k 3.2×	1.2k 1.3×	784 1.9×	706 1.9×	627 1.8×	40	4.2k
André M. Siqueira Brazil	34	1.1k 1.0×	2.8k 3.2×	586 1.4×	280 0.8×	204 0.6×	117	3.6k
Deborah Cromer Australia	25	2.9k 2.6×	406 0.5×	597 1.5×	624 1.7×	520 1.5×	70	4.0k
Soren Gantt Canada	27	795 0.7×	493 0.6×	1.1k 2.8×	426 1.2×	390 1.1×	109	2.4k
Pierre Delobel France	33	1.7k 1.6×	625 0.7×	751 1.9×	497 1.4×	307 0.9×	127	2.9k

Countries citing papers authored by Thomas Luke

Since Specialization

Citations

This map shows the geographic impact of Thomas Luke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Luke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Luke more than expected).

Fields of papers citing papers by Thomas Luke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Luke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Luke. The network helps show where Thomas Luke may publish in the future.

Co-authorship network of co-authors of Thomas Luke

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Luke. A scholar is included among the top collaborators of Thomas Luke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Luke. Thomas Luke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brocato, Rebecca L., Hua Wu, Steven A. Kwilas, et al.. (2024). Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human source. mBio. 15(10). e0160024–e0160024. 1 indexed citations

Wang, Zhao, Chithra Sreenivasan, Zizhang Sheng, et al.. (2023). A fully human monoclonal antibody possesses antibody‐dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a conserved epitope at the HA1 protomer interface. Journal of Medical Virology. 95(7). e28901–e28901. 5 indexed citations

Wu, Hua, Christopher P. Klimko, Kristi A. Egland, et al.. (2023). Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague. Antibodies. 12(2). 33–33. 1 indexed citations

Tang, Juanjie, Gabrielle Grubbs, Youri Lee, et al.. (2022). Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019. The Journal of Infectious Diseases. 226(4). 655–663. 3 indexed citations

Duplessis, Christopher, et al.. (2021). Skin Swabbing for Staphylococcus aureus–Targeting Phages. Military Medicine. 188(3-4). e463–e467. 2 indexed citations

Liu, Zhuoming, Hua Wu, Kristi A. Egland, et al.. (2021). Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants. Human Vaccines & Immunotherapeutics. 18(2). 1940652–1940652. 16 indexed citations

Beigel, John H., Jocelyn Voell, Parag Kumar, et al.. (2018). Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study. The Lancet Infectious Diseases. 18(4). 410–418. 86 indexed citations

Morrison, Brian J., Nicholas J. Martin, Tauseef Ur Rehman, et al.. (2018). Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays. BMC Health Services Research. 18(1). 651–651. 6 indexed citations

Danko, Janine, Tadeusz J. Kochel, Nimfa Teneza-Mora, et al.. (2018). Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial. American Journal of Tropical Medicine and Hygiene. 98(3). 849–856. 64 indexed citations

10.

Arabi, Yaseen M., Hanan H. Balkhy, Frederick G. Hayden, et al.. (2017). Middle East Respiratory Syndrome. New England Journal of Medicine. 376(6). 584–594. 373 indexed citations breakdown →

11.

Morrison, Brian J., Jessica Roman, Thomas Luke, et al.. (2017). Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy. Journal of Virological Methods. 248. 7–18. 10 indexed citations

12.

Gardner, Christina L., Chengqun Sun, Thomas Luke, et al.. (2017). Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus. Journal of Virology. 91(14). 32 indexed citations

13.

Raviprakash, Kanakatte, Peifang Sun, Yossef Raviv, et al.. (2013). Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4′-aminomethyl-trioxsalen) is highly immunogenic in mice. Human Vaccines & Immunotherapeutics. 9(11). 2336–2341. 22 indexed citations

14.

Poland, Gregory A., et al.. (2013). New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. Vaccine. 31. A1–A20. 9 indexed citations

15.

Raviprakash, Kanakatte, Thomas Luke, John A. Doukas, et al.. (2012). A dengue DNA vaccine formulated with Vaxfectin^®is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits. Human Vaccines & Immunotherapeutics. 8(12). 1764–1768. 15 indexed citations

16.

Defang, Gabriel, Nicholas J. Martin, Timothy Burgess, et al.. (2012). Comparative Analysis of Hemagglutination Inhibition Titers Generated Using Temporally Matched Serum and Plasma Samples. PLoS ONE. 7(12). e48229–e48229. 19 indexed citations

17.

Luke, Thomas, Arturo Casadevall, Stanley J. Watowich, et al.. (2010). Hark back: Passive immunotherapy for influenza and other serious infections. Critical Care Medicine. 38(4 Suppl). e66–e73. 109 indexed citations

18.

Epstein, Judith E., Suchitra Rao, Frank B. Williams, et al.. (2007). Safety and Clinical Outcome of Experimental Challenge of Human Volunteers withPlasmodium falciparum–Infected Mosquitoes: An Update. The Journal of Infectious Diseases. 196(1). 145–154. 89 indexed citations

19.

Luke, Thomas, et al.. (2006). Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?. Annals of Internal Medicine. 145(8). 599–609. 436 indexed citations

20.

Hoffman, Stephen L., Thomas Luke, Imogene Schneider, et al.. (2002). Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoites. The Journal of Infectious Diseases. 185(8). 1155–1164. 526 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact